{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:11:32Z","timestamp":1793171492299,"version":"4.5.0"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2019,8,20]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Charcot arthropathy is one of the disabling diabetes complications. There are\nenigmatic areas concerning its underlying pathophysiology and risk predictors. Osteoporosis and local\nosteopenia have been postulated to have a role in Charcot arthropathy development, but it is still\ncontroversial.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The study aims to compare bone mineral density among type 2 diabetics with and without\nCharcot arthropathy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Two groups with type 2 diabetes participated in this study; Group I [30] patients with\nCharcot arthropathy while Group II [30] patients without charcot arthropathy. All patients underwent\nfull clinical examination and complete history taking with special emphasis on foot problems. Laboratory\ninvestigations were done that included fasting blood sugar, postprandial blood sugar, glycosylated\nhemoglobin, serum calcium, serum phosphorus, and alkaline phosphatase. All patients underwent MRI\nfor both feet and dual energy X-ray absorptiometry scan of the lumbar spine and femur. The demographic\ndata, clinical data, the presence or absence of comorbidities and bone mineral density were\ncompared for both groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Bone mineral density was significantly lower in Group I than Group II with median lumber T\nscore (-0.15, 1.99 p &lt;0.001), median Femur T score (0.050, 2.400, p &lt;0.001). Group I showed higher\npropensity for hypertension, neuropathy, micro-albuminuria with peripheral arterial disease (23.33 %)\ncompared to Group II (p &lt;0.001). Multiple logistic regression analysis revealed that female gender and\nlow femur bone mineral density can be risk predictors of the condition.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Bone mineral density is lower in patients with Charcot arthropathy with female gender\nand Femur T score as risk predictors. Peripheral arterial disease shows greater incidence in Charcot patients\nthan was previously reported.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399814666180711115845","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T11:51:16Z","timestamp":1531309876000},"page":"395-401","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bone Mineral Density in Type 2 Diabetes Patients with Charcot Arthropathy"],"prefix":"10.2174","volume":"15","author":[{"given":"Hussein A.","family":"El Oraby","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Ain Shams University Hospitals, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"Abdelsalam","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Ain Shams University Hospitals, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara M.","family":"Eid","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Ain Shams University Hospitals, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"El Hilaly","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University Hospitals, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Marzouk","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Ain Shams University Hospitals, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"16","volume":"18","author":"Giurini J.","year":"2005","unstructured":"Giurini J.; A closer look at fixation options for the Charcot foot. Pod Today 2005,18(11),16-21","journal-title":"Pod Today"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1002\/1520-7560(200009\/10)16:1+<::AID-DMRR134>3.0.CO;2-N","volume":"16","author":"Frykberg R.G.","year":"2000","unstructured":"Frykberg R.G.; Mendeszoon E.; Management of the diabetic charcot foot. Diabetes Metab Res Rev 2000,16(1),S59-S65","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1464-5491.2000.00233.x","volume":"17","author":"Jeffcoate W.","year":"2000","unstructured":"Jeffcoate W.; Lima J.; Nobrega L.; The Charcot foot. Diabet Med 2000,17,253-258","journal-title":"Diabet Med"},{"key":"ref=4","first-page":"221","author":"Frykberg R.G.","year":"2002","unstructured":"Frykberg R.G.;  Medical and Surgical Management, edited by Veves A, Giurini J, and LoGerfo FW,2002,221-46","journal-title":"Medical and Surgical Management,"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107110070502600109","volume":"26","author":"Trepman E.","year":"2005","unstructured":"Trepman E.; Nihal A.; Pinzur M.S.; Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int 2005,26(1),46-63","journal-title":"Foot Ankle Int"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1302\/0301-620X.86B3.14593","volume":"86-B","author":"Herbst S.A.","year":"2004","unstructured":"Herbst S.A.; Jones K.B.; Saltzman C.L.; Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J\nBone Joint Surg Published 1 April 2004.2004,86-B,378-383","journal-title":"J\nBone Joint Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1464-5491.2001.00511.x","volume":"18","author":"Jirkovska A.","year":"2001","unstructured":"Jirkovska A.; Kasalicky P.; Boucek P.; Hosova J.; Skibova J.; Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med 2001,18(6),495-500","journal-title":"Diabet Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0140-6736(05)67029-8","volume":"366","author":"Jeffcoate W.J.","year":"2005","unstructured":"Jeffcoate W.J.; Game F.; Cavanagh P.R.; The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005,366,2058-2061","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.foot.2015.11.001","volume":"26","author":"La Fontaine J.","year":"2016","unstructured":"La Fontaine J.; Lavery L.; Jude E.; Current concepts of Charcot foot\nin diabetic patients. Foot (Edinb) [Internet] Available from: 2016,26,7-14","journal-title":"Foot (Edinb) [Internet]"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"Rogers L.C.","year":"2011","unstructured":"Rogers L.C.; Frykberg R.G.; Armstrong D.G.; The charcot foot in diabetes. Diabetes Care 2011,34(9),2123-2129","journal-title":"Diabetes Care"},{"key":"ref=11","author":"Jung RH","unstructured":"Jung RH; Greenhagen RM; Wukich DW; Charcot neuroarthropathy\nand bone mineral density. LER Magazine","journal-title":"LER Magazine"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1475-097X.2009.00915.x","volume":"30","author":"Christensen T.M.","year":"2010","unstructured":"Christensen T.M.; Bulow J.; Simonsen L.; Bone mineral density in diabetes mellitus patients with and without a Charcot foot. Clin Physiol Funct Imaging 2010,30,130-134","journal-title":"Clin Physiol Funct Imaging"},{"key":"ref=13","first-page":"191","volume":"15","author":"Leung H.B.","year":"2009","unstructured":"Leung H.B.; Ho Y.C.; Wong W.C.; Charcot foot in a Hong Kong Chinese diabetic population. Hong Kong Med J 2009,15(3),191-195","journal-title":"Hong Kong Med J"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1464-5491.2000.00298.x","volume":"17","author":"Winkler A.S.","year":"2000","unstructured":"Winkler A.S.; Ejskjaer N.; Edmonds M.; Dissociated sensory loss in diabetic autonomic neuropathy. Diabet Med 2000,17(6),457-462","journal-title":"Diabet Med"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00402547","volume":"35","author":"Stevens M.J.","year":"1992","unstructured":"Stevens M.J.; Edmonds M.E.; Foster A.V.; Watkins P.J.; Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 1992,35(2),148-154","journal-title":"Diabetologia"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.2337\/dc11-0764","volume":"34","author":"Eller-Vainicher C.","year":"2011","unstructured":"Eller-Vainicher C.; Zhukouskaya V.V.; Tolkachev Y.V.; Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis. Diabetes Care 2011,34(10),2186-2191","journal-title":"Diabetes Care"},{"key":"ref=17","first-page":"335","volume":"120","author":"S\u00e4mann A.","unstructured":"S\u00e4mann A.; Pofahl S.; Lehmann T.; Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet. Exp Clin Endocrinol Diabetes ,120(6),335-339","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"268390","DOI":"10.1155\/2015\/268390","author":"Tuttolomondo A.","year":"2015","unstructured":"Tuttolomondo A.; Maida C.; Pinto A.;  Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients 2015,268390","journal-title":"Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","volume":"57","author":"Zoungas S.","year":"2014","unstructured":"Zoungas S.; Woodward M.; Li Q.; ADVANCE Collaborative\ngroup. Impact of age, age at diagnosis and duration of diabetes on\nthe risk of macrovascular and microvascular complications and\ndeath in type 2 diabetes. Diabetologia 2014,57(12),2465-2474","journal-title":"Diabetologia"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1464-5491.2011.03442.x","volume":"29","author":"Korzon-Burakowska A.","year":"2012","unstructured":"Korzon-Burakowska A.; Jak\u00f3bkiewicz-Banecka J.; Fiedosiuk A.; Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med 2012,29(6),771-775","journal-title":"Diabet Med"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00125-002-0885-7","volume":"45","author":"Rajbhandari S.M.","year":"2002","unstructured":"Rajbhandari S.M.; Jenkins R.C.; Davies C.; Tesfaye S.; Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002,45,1085-1096","journal-title":"Diabetologia"},{"key":"ref=22","author":"Bem R.","year":"2012","unstructured":"Bem R.; Jirkovska A.;  Diabetes Centre Institute for Clinical and Experimental Medicine, Prague.2012","journal-title":"Diabetes Centre"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/j.jfas.2016.01.051","volume":"55","author":"Wukich D.K.","year":"2017","unstructured":"Wukich D.K.; Raspovic K.M.; Suder N.C.; Prevalence of peripheral arterial disease in patients with diabetic charcot neuroarthropathy. J Foot Ankle Surg 2017,55(4),727-731","journal-title":"J Foot Ankle Surg"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4239\/wjd.v2.i5.59","volume":"2","author":"Gouveri E.","year":"2011","unstructured":"Gouveri E.; Papanas N.; Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes 2011,2(5),59-65","journal-title":"World J Diabetes"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2337\/dc08-1695","volume":"32","author":"Sohn M.W.","year":"2009","unstructured":"Sohn M.W.; Lee T.A.; Stuck R.M.; Frykberg R.G.; Budiman-Mak E.; Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 2009,32(5),816-821","journal-title":"Diabetes Care"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.3402\/dfa.v4i0.21117","volume":"4","author":"Kaynak G.","year":"2013","unstructured":"Kaynak G.; Birsel O.; G\u00fcven M.F.; \u00d6\u011f\u00fct T.; An overview of the Charcot foot pathophysiology. Diabet Foot Ankle 2013,4","journal-title":"Diabet Foot Ankle"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00198-013-2511-6","volume":"25","author":"Petrova N.L.","year":"2014","unstructured":"Petrova N.L.; Shanahan C.M.; Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy. Osteoporos Int 2014,25(4),1197-1207","journal-title":"Osteoporos Int"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13018-017-0634-8","volume":"12","author":"Zhao H-M.","year":"2017","unstructured":"Zhao H-M.; Diao J-Y.; Liang X-J.; Zhang F.; Hao D-J.; Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy. J Orthop Surg Res 2017,12,142","journal-title":"J Orthop Surg Res"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T07:50:48Z","timestamp":1570607448000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163679\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399814666180711115845","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}